Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Human Vaccines & Immunotherapeutics|December 20, 2012
The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosisMasaji Okada, Yoko Kita, Toshihiro Nakajima, et al.
The American Journal of Tropical Medicine and Hygiene|May 14, 2005
A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosumLaarni G Villahermosa, Tranquilino T Fajardo, Rodolfo M Abalos, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Transmission of dapsone-resistant leprosy detected by molecular epidemiological approachesWei Li, Rama M Sakamuri, Danielle E Lyons, et al.
The Medical Journal of Malaysia|January 30, 2023
Prevalence of COVID-19 among healthcare workers in the paediatric department: Estimates from a multicenter cross-sectional survey in Negeri SembilanN C E David, H Juliana, M Chok, et al.
Clinical and Vaccine Immunology : CVI|December 18, 2009
Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosisMalcolm S Duthie, Marah N Hay, Cecile Z Morales, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 25, 2019
Functional outcome and muscle wasting in adults with tetanusTruong N Trung, Nguyen V T Duoc, Le T H Nhat, et al.
Procedia in Vaccinology|April 15, 2020
A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey ModelM Okada, Y Kita, T Nakajima, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
Vaccine|February 10, 2009
Novel prophylactic and therapeutic vaccine against tuberculosisMasaji Okada, Yoko Kita, Toshihiro Nakajima, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeysSteven G Reed, Rhea N Coler, Wilfried Dalemans, et al.
Pageof 18